Effect of Moxonidine and Cilazapril on Microcirculation as Assessed by Finger Nailfold Capillaroscopy in Mild-to-Moderate Hypertension

Abstract

Disorders in peripheral microcirculation are observed in arterial hypertension and may be improved by antihypertensive treatment. In this pilot study the authors measured capillary blood cell velocity in the finger nailfold in 14 patients (mean age 50 ± 14 years, range 30-71 years; 9 men, 5 women) with mild-to-moderate essential hypertension. After a 3-week placebo period, patients received double-blind randomized treatment with either 0.2- to 0.4-mg moxonidine (n=7) or 2.5- to 5.0-mg cilazapril (n=7). Finger nailfold video capillaroscopy was performed at baseline and after 8 weeks of treatment. Blood pressure was measured by conventional office technique.

Capillary blood cell velocity, 1 minute after local finger cooling, increased in the Moxonidine group (0.65 ±0.53 mm/sec to 1.13 ±0.77 mm/sec; p<0.05) after 8 weeks treatment compared to the baseline. The increase in the Cilazapril group from 0.79 ±0.45 mm/sec to 0.93 ±1.03 mm/sec did not reach a level of statistical significance. Blood pressure decreased from 151 ±8/101 ± 5 to 147 ±6/98 ± 7 mmHg in the Moxonidine group and from 164 ± 12/102 ±6 to 140 ±9/93 ±9 mmHg in the cilazapril group.

Moxonidine increased nailfold capillary blood cell velocity 1 minute after local finger cooling in patients with mild-to-moderate hypertension. This improvement of the peripheral microcirculation may be associated with reversal of vascular dysfunction in hypertension.

Get full access to this article

View all access options for this article.

References

Bühler RF , Bolli P. , Hulthèn UL, et al : Alpha-adrenoceptors, adrenaline and exaggerated vasoconstrictor response to stress in essential hypertension Chest 83 (Suppl 2):304S-306S, 1983.

Roman MJ , Saba PS , Pini R., et al : Parallel cardiac and vascular adaptation in hypertension Circulation 86:1909-1918, 1992.

Gasser P. , Bühler FR : Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by videomicroscopy J Hypertens 10:83-86, 1992.

Motz W. , Strauer BE : Improvement of coronary flow reserve after long-term therapy with enalapril Hypertension 27:1031-1038, 1996 .

Weinbacher M. , Martina B. , Gasser P., et al : Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension. Results of 24-hour ambulatory blood pressure monitoring. J Cardiovasc Pharmacol 24 (Suppl 3):S83-S85, 1994.

Mitrowic V. , Patyna W. , Hüting J., et al : Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension Cardiovasc Drugs Ther 5:967-972, 1991.

Eichstädt H. , Richter W. , Bäder M. : Demonstration of hypertrophy regression with magnetic resonance tomography under the new adrenergic inhibitor moxonidine Cardiovasc Drugs Ther 3:583-587, 1989.

Motz W. , Vogt M. , Scheler S., et al : Hypertensive coronary microcirculation effects of the imidazoline-receptor-agonist moxonidine Cardiovasc Risk Factors 5 (Suppl 1):28-32, 1995.

Küppers H. , Jäger B. , Luszick JH, et al : Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension. J Hypertens 15:93-97, 1997.

10.

Kraft K. , Vetter H. : Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension : Moxonidine versus captopril J Cardiovasc Pharmacol 24 (Suppl 1):S29-S35, 1994.

11.

Prichard Bnc , Graham BR : The use of moxonidine in the treatment of hypertension J Hypertens 15 (Suppl 1):S47-S55, 1997.

12.

Gasser P. : Capillary blood cell velocity in finger nailfold : Characteristics and reproducibility of the local cold response Microvasc Res 40:29-35, 1990.

13.

Shore AC , Tooke JE : Microvascular function in human essential hypertension J Hypertens 12:717-728, 1994.